| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 1 |
| GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: Q4Q517
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 281 | 285 | PF00656 | 0.561 |
| CLV_C14_Caspase3-7 | 365 | 369 | PF00656 | 0.808 |
| CLV_PCSK_SKI1_1 | 318 | 322 | PF00082 | 0.420 |
| DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.476 |
| DOC_CKS1_1 | 89 | 94 | PF01111 | 0.561 |
| DOC_MAPK_gen_1 | 252 | 262 | PF00069 | 0.479 |
| DOC_MAPK_gen_1 | 303 | 313 | PF00069 | 0.555 |
| DOC_MAPK_HePTP_8 | 217 | 229 | PF00069 | 0.489 |
| DOC_MAPK_MEF2A_6 | 220 | 229 | PF00069 | 0.493 |
| DOC_MAPK_MEF2A_6 | 306 | 315 | PF00069 | 0.461 |
| DOC_PP1_RVXF_1 | 114 | 121 | PF00149 | 0.469 |
| DOC_PP1_RVXF_1 | 173 | 179 | PF00149 | 0.363 |
| DOC_USP7_MATH_1 | 129 | 133 | PF00917 | 0.446 |
| DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.450 |
| DOC_USP7_MATH_1 | 93 | 97 | PF00917 | 0.459 |
| DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.384 |
| DOC_WW_Pin1_4 | 18 | 23 | PF00397 | 0.751 |
| DOC_WW_Pin1_4 | 88 | 93 | PF00397 | 0.497 |
| LIG_14-3-3_CanoR_1 | 157 | 163 | PF00244 | 0.420 |
| LIG_14-3-3_CanoR_1 | 252 | 262 | PF00244 | 0.323 |
| LIG_BIR_III_2 | 284 | 288 | PF00653 | 0.539 |
| LIG_FHA_1 | 228 | 234 | PF00498 | 0.426 |
| LIG_FHA_1 | 24 | 30 | PF00498 | 0.501 |
| LIG_FHA_1 | 296 | 302 | PF00498 | 0.468 |
| LIG_FHA_1 | 59 | 65 | PF00498 | 0.470 |
| LIG_FHA_1 | 80 | 86 | PF00498 | 0.427 |
| LIG_FHA_2 | 319 | 325 | PF00498 | 0.370 |
| LIG_FHA_2 | 33 | 39 | PF00498 | 0.479 |
| LIG_LIR_Apic_2 | 237 | 243 | PF02991 | 0.377 |
| LIG_LIR_Gen_1 | 156 | 165 | PF02991 | 0.512 |
| LIG_LIR_Gen_1 | 264 | 272 | PF02991 | 0.486 |
| LIG_LIR_Nem_3 | 156 | 162 | PF02991 | 0.533 |
| LIG_LIR_Nem_3 | 256 | 261 | PF02991 | 0.524 |
| LIG_LIR_Nem_3 | 264 | 268 | PF02991 | 0.465 |
| LIG_PROFILIN_1 | 8 | 14 | PF00235 | 0.464 |
| LIG_PTAP_UEV_1 | 137 | 142 | PF05743 | 0.523 |
| LIG_SH2_PTP2 | 240 | 243 | PF00017 | 0.443 |
| LIG_SH2_SRC | 37 | 40 | PF00017 | 0.581 |
| LIG_SH2_STAP1 | 67 | 71 | PF00017 | 0.540 |
| LIG_SH2_STAT3 | 67 | 70 | PF00017 | 0.469 |
| LIG_SH2_STAT3 | 99 | 102 | PF00017 | 0.385 |
| LIG_SH2_STAT5 | 240 | 243 | PF00017 | 0.391 |
| LIG_SH2_STAT5 | 261 | 264 | PF00017 | 0.382 |
| LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.401 |
| LIG_SH3_1 | 7 | 13 | PF00018 | 0.465 |
| LIG_SH3_3 | 135 | 141 | PF00018 | 0.515 |
| LIG_SH3_3 | 5 | 11 | PF00018 | 0.467 |
| LIG_SH3_3 | 86 | 92 | PF00018 | 0.454 |
| LIG_TRAF2_1 | 197 | 200 | PF00917 | 0.551 |
| MOD_CK1_1 | 58 | 64 | PF00069 | 0.409 |
| MOD_CK2_1 | 183 | 189 | PF00069 | 0.352 |
| MOD_CK2_1 | 194 | 200 | PF00069 | 0.382 |
| MOD_CK2_1 | 253 | 259 | PF00069 | 0.343 |
| MOD_CK2_1 | 318 | 324 | PF00069 | 0.369 |
| MOD_CK2_1 | 32 | 38 | PF00069 | 0.446 |
| MOD_GlcNHglycan | 126 | 129 | PF01048 | 0.515 |
| MOD_GlcNHglycan | 138 | 141 | PF01048 | 0.471 |
| MOD_GlcNHglycan | 185 | 188 | PF01048 | 0.339 |
| MOD_GlcNHglycan | 268 | 271 | PF01048 | 0.508 |
| MOD_GlcNHglycan | 275 | 278 | PF01048 | 0.504 |
| MOD_GlcNHglycan | 280 | 284 | PF01048 | 0.566 |
| MOD_GlcNHglycan | 347 | 350 | PF01048 | 0.680 |
| MOD_GlcNHglycan | 368 | 371 | PF01048 | 0.784 |
| MOD_GlcNHglycan | 378 | 381 | PF01048 | 0.778 |
| MOD_GSK3_1 | 130 | 137 | PF00069 | 0.377 |
| MOD_GSK3_1 | 14 | 21 | PF00069 | 0.557 |
| MOD_GSK3_1 | 336 | 343 | PF00069 | 0.550 |
| MOD_GSK3_1 | 345 | 352 | PF00069 | 0.593 |
| MOD_GSK3_1 | 51 | 58 | PF00069 | 0.383 |
| MOD_GSK3_1 | 66 | 73 | PF00069 | 0.314 |
| MOD_GSK3_1 | 93 | 100 | PF00069 | 0.413 |
| MOD_N-GLC_1 | 49 | 54 | PF02516 | 0.494 |
| MOD_NEK2_1 | 124 | 129 | PF00069 | 0.463 |
| MOD_NEK2_1 | 153 | 158 | PF00069 | 0.420 |
| MOD_NEK2_1 | 227 | 232 | PF00069 | 0.518 |
| MOD_NEK2_1 | 358 | 363 | PF00069 | 0.752 |
| MOD_NEK2_1 | 55 | 60 | PF00069 | 0.392 |
| MOD_NEK2_1 | 66 | 71 | PF00069 | 0.422 |
| MOD_NEK2_1 | 97 | 102 | PF00069 | 0.440 |
| MOD_PIKK_1 | 295 | 301 | PF00454 | 0.528 |
| MOD_PIKK_1 | 58 | 64 | PF00454 | 0.501 |
| MOD_PIKK_1 | 66 | 72 | PF00454 | 0.505 |
| MOD_PKA_2 | 248 | 254 | PF00069 | 0.571 |
| MOD_PKA_2 | 376 | 382 | PF00069 | 0.730 |
| MOD_Plk_1 | 171 | 177 | PF00069 | 0.361 |
| MOD_Plk_4 | 38 | 44 | PF00069 | 0.458 |
| MOD_Plk_4 | 70 | 76 | PF00069 | 0.487 |
| MOD_Plk_4 | 93 | 99 | PF00069 | 0.403 |
| MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.382 |
| MOD_ProDKin_1 | 18 | 24 | PF00069 | 0.741 |
| MOD_ProDKin_1 | 88 | 94 | PF00069 | 0.496 |
| MOD_SUMO_rev_2 | 174 | 184 | PF00179 | 0.434 |
| TRG_DiLeu_BaLyEn_6 | 138 | 143 | PF01217 | 0.524 |
| TRG_DiLeu_BaLyEn_6 | 315 | 320 | PF01217 | 0.486 |
| TRG_ER_diArg_1 | 175 | 178 | PF00400 | 0.348 |
| TRG_ER_diArg_1 | 387 | 390 | PF00400 | 0.714 |
| TRG_Pf-PMV_PEXEL_1 | 177 | 181 | PF00026 | 0.382 |
| TRG_Pf-PMV_PEXEL_1 | 83 | 87 | PF00026 | 0.334 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I8A3 | Leptomonas seymouri | 77% | 100% |
| A0A0S4J2R9 | Bodo saltans | 43% | 100% |
| A0A1X0NRV1 | Trypanosomatidae | 43% | 100% |
| A0A3Q8IDA1 | Leishmania donovani | 96% | 88% |
| A0A3R7L0G4 | Trypanosoma rangeli | 54% | 100% |
| A4HKP8 | Leishmania braziliensis | 86% | 100% |
| A4I879 | Leishmania infantum | 95% | 88% |
| D0AAE8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 100% |
| E9B337 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
| V5BET5 | Trypanosoma cruzi | 51% | 94% |